Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Cancer Drug Targets, Volume 19 - Number 7
Perspective Open Access
Cancer Epigenetics: Clinical Perspectives
, 19(7): 513 - 514Aamir Ahmad
DOI: 10.2174/156800961907190802112321
Review Article
HSF1 as a Cancer Biomarker and Therapeutic Target
, 19(7): 515 - 524Richard L. Carpenter* and Yesim Gokmen-Polar
DOI: 10.2174/1568009618666181018162117
HSF1 as a Cancer Biomarker and Therapeutic Target
Review Article
Nanotherapy Targeting the Tumor Microenvironment
, 19(7): 525 - 533Bo-Shen Gong, Rui Wang, Hong-Xia Xu, Ming-Yong Miao* and Zhen-Zhen Yao*
DOI: 10.2174/1568009619666181220103714
Nanotherapy Targeting the Tumor Microenvironment
Review Article
Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer
, 19(7): 534 - 550Gang Wang, Jun-Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao* and Xing-Li Fu*
DOI: 10.2174/1568009618666181015150138
Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer
Research Article
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan’s Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea
, 19(7): 551 - 560Rongjin Sun, Sumit Basu, Min Zeng, Robin Sunsong, Li Li, Romi Ghose, Wei Wang, Zhongqiu Liu, Ming Hu* and Song Gao*
DOI: 10.2174/1568009618666181029153255
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan’s Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea
Research Article
Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
, 19(7): 561 - 570Hamidreza Maroof , Soussan Irani , Armin Arianna, Jelena Vider, Vinod Gopalan and Alfred King-yin Lam *
DOI: 10.2174/1568009618666180628154727
Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
Research Article
Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
, 19(7): 571 - 582Jia Wei, Ling Ma, Chenglong Li, Christopher R. Pierson, Jonathan L. Finlay and Jiayuh Lin*
DOI: 10.2174/1568009618666181016165604
Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
Research Article
EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway
, 19(7): 583 - 593Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen*, Feng Feng* and Wei Qu*
DOI: 10.2174/1568009619666181226094814
EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net